SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech firesales -- Ignore unavailable to you. Want to Upgrade?


To: tnsaf who wrote (3115)5/9/2016 5:58:33 PM
From: tuck  Read Replies (1) | Respond to of 3661
 
NewLink Genetics (NLNK) off 35% AH on P3 failure in pancreatic cancer. I don't follow this outfit closely, but they compete with Incyte in the IDO inhibitor space, and they just became a purer play on that program ( there is another one). Could be worth looking over the wreckage. Certainly not calling for a table pounding buy.

Cheers, Tuck